Intranasal Ketorolac Tromethamine
Drug30 mg ketorolac will be administered intranasally using mucosal atomizer. Half dose (0.5 cc) in each nostril, Given 5 minutes before digital nerve block.
NCT Number: NCT07305883
This study aims to compare the analgesic effectiveness and side effects of intranasal ketorolac versus intranasal ketamine for reducing pain prior to digital nerve block procedures in patients with finger injuries in emergency department.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Phase 3
Acute pain management in emergency department during painful procedures such as digital nerve block is crucial to be implemented in a rapid-onset method. Ketorolac, a potent NSAID, and ketamine, an NMDA receptor antagonist with analgesic effects, have both been shown to be effective and fast-onset when administered intranasally. This non-invasive method of Ketorolac is not supported by sufficient evidences in such clinical scenarios. Addressing this research gap may lead to reduced pain and complications, as well as higher patient satisfaction, contributing the development of novel pre-procedural analgesic strategies in emergency settings.
Participants will be randomly assigned to receive either 30 mg intranasal ketorolac or 50 mg intranasal ketamine, administered 5 minutes prior to the digital nerve block. Pain will be assessed using the Numeric Rating Scale (NRS). Secondary endpoints include nasal irritation, side effects, and patient satisfaction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 mg ketorolac will be administered intranasally using mucosal atomizer. Half dose (0.5 cc) in each nostril, Given 5 minutes before digital nerve block.
50 mg ketamine will be administered intranasally using mucosal atomizer,. Half dose (0.5cc) in each nostril, Given 5 minutes before digital nerve block
Time frame: Immediately after block
The numerical rating score (NRS) will be used for the study. The NRS ranges from 0 (no pain) to 10 (very severe pain). The higher the pain scores the higher the pain severity. The pain severity will be asked from the patients.
Time frame: 60 minutes after the block
We will ask the patients about this outcome use a 3-level Likert-like scale.
Time frame: From the drug administration to 60 minutes after the block
The patients will be assessed every 15 minutes for this outcome.
Time frame: 60 minutes after the drug administration.
The patients will be asked about their satisfaction using a 3-level Likert like scale.
Contact information is provided by the study sponsor or research team.
Tehran University of Medical Sciences
Other
Intranasal Ketorolac Effectiveness In Comparison To Intranasal Ketamine for Digital Nerve Block Pain; A Randomized, Double Blind Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712874
Neurologic Manifestations, Pain
Bethesda, Maryland, United States
View Trial DetailsNCT07738965
Chronic Non Specific Low Back Pain, Core Strength
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07739771
Behavior, Chemotherapeutic Toxicity
Madrid, Spain
View Trial DetailsNCT07737392
Behavior, Health Behavior
Houston, Texas, United States
View Trial Details